|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q96076822
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000140.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q96076822
|
|
024
|
|
|
‡a
0000-0003-0057-0938
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q96076822
|
|
100
|
0 |
|
‡a
Gerrit Meijer
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
G A Meijer
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
|
|
670
|
|
|
‡a
Author's Abstract 109: CSE1L, a 20q gain passenger that drives colorectal adenoma to carcinoma progression
|
|
670
|
|
|
‡a
Author's Abstract 3042: TPX2 and AURKA promote 20q amplicon driven colorectal adenoma-to-carcinoma progression
|
|
670
|
|
|
‡a
Author's Abstract 3397: Patterns of DNA copy number changes in colorectal cancer metastasis are highly similar to their corresponding primaries with additional focal alterations that differ between individual patients
|
|
670
|
|
|
‡a
Author's Abstract 3426: A novel approach to copy number assessment by whole genome sequencing reveals extensive spatial heterogeneity in diffuse low-grade glioma
|
|
670
|
|
|
‡a
Author's Abstract 4526: Lumican and Versican predict good outcome in stage II and III colon cancer
|
|
670
|
|
|
‡a
Author's Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability
|
|
670
|
|
|
‡a
Author's Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations
|
|
670
|
|
|
‡a
Author's Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options
|
|
670
|
|
|
‡a
Author's Alternative Cleavage and Polyadenylation during Colorectal Cancer Development
|
|
670
|
|
|
‡a
Author's American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond—Lessons Learned and Member Institutions’ Perspectives
|
|
670
|
|
|
‡a
Author's Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
|
|
670
|
|
|
‡a
Author's Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces
|
|
670
|
|
|
‡a
Author's Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand
|
|
670
|
|
|
‡a
Author's Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies
|
|
670
|
|
|
‡a
Author's Assessing opportunities for coordinated R&D in early cancer detection and management in Europe
|
|
670
|
|
|
‡a
Author's Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.
|
|
670
|
|
|
‡a
Author's BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH)
|
|
670
|
|
|
‡a
Author's Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications.
|
|
670
|
|
|
‡a
Author's Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel
|
|
670
|
|
|
‡a
Author's BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain
|
|
670
|
|
|
‡a
Author's Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
|
|
670
|
|
|
‡a
Author's Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions
|
|
670
|
|
|
‡a
Author's Breakpoint identification and smoothing of array comparative genomic hybridization data
|
|
670
|
|
|
‡a
Author's Bridging the translational innovation gap through good biomarker practice.
|
|
670
|
|
|
‡a
Author's Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening?
|
|
670
|
|
|
‡a
Author's Candidate driver genes in focal chromosomal aberrations of stage II colon cancer
|
|
670
|
|
|
‡a
Author's Carcinoma origin dictates differential skewing of monocyte function
|
|
670
|
|
|
‡a
Author's CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
|
|
670
|
|
|
‡a
Author's Cell cycle proteins predict recurrence in stage II and III colon cancer.
|
|
670
|
|
|
‡a
Author's Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
|
|
670
|
|
|
‡a
Author's Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
|
|
670
|
|
|
‡a
Author's Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas.
|
|
670
|
|
|
‡a
Author's Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters
|
|
670
|
|
|
‡a
Author's CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material
|
|
670
|
|
|
‡a
Author's CGHpower: exploring sample size calculations for chromosomal copy number experiments
|
|
670
|
|
|
‡a
Author's Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma.
|
|
670
|
|
|
‡a
Author's Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent
|
|
670
|
|
|
‡a
Author's Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
|
|
670
|
|
|
‡a
Author's Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal cancer
|
|
670
|
|
|
‡a
Author's Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer
|
|
670
|
|
|
‡a
Author's Chromosome 5q loss in colorectal flat adenomas.
|
|
670
|
|
|
‡a
Author's Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer
|
|
670
|
|
|
‡a
Author's Colonoscopic yield of colorectal neoplasia in daily clinical practice
|
|
670
|
|
|
‡a
Author's Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
|
|
670
|
|
|
‡a
Author's Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
|
|
670
|
|
|
‡a
Author's Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling
|
|
670
|
|
|
‡a
Author's Colorectal cancer epigenetics: complex simplicity
|
|
670
|
|
|
‡a
Author's Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
|
|
670
|
|
|
‡a
Author's [Colorectal carcinoma in the Netherlands: the situation before and after population surveillance]
|
|
670
|
|
|
‡a
Author's Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer
|
|
670
|
|
|
‡a
Author's Comment re: a comparison of DNA copy number profiling platforms
|
|
670
|
|
|
‡a
Author's Comparative evaluation of genetic assays to identify oral pre-cancerous fields
|
|
670
|
|
|
‡a
Author's Comparative genomic hybridization in cancer investigations
|
|
670
|
|
|
‡a
Author's Comprehensive mutation analysis in colorectal flat adenomas
|
|
670
|
|
|
‡a
Author's Computer-assisted estimation in the CNS of 3D multimarker 'overlap' or 'touch' at the level of individual nerve endings: a confocal laser scanning microscope application.
|
|
670
|
|
|
‡a
Author's Consensus molecular subtype classification of colorectal adenomas
|
|
670
|
|
|
‡a
Author's Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
|
|
670
|
|
|
‡a
Author's Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
|
|
670
|
|
|
‡a
Author's Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening
|
|
670
|
|
|
‡a
Author's CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
|
|
670
|
|
|
‡a
Author's Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
|
|
670
|
|
|
‡a
Author's Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
|
|
670
|
|
|
‡a
Author's Detection limits of DNA copy number alterations in heterogeneous cell populations
|
|
670
|
|
|
‡a
Author's Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization
|
|
670
|
|
|
‡a
Author's Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps
|
|
670
|
|
|
‡a
Author's [Diagnosis of colorectal tumours in daily clinical practice: comparison of colonoscopy and sigmoidoscopy]
|
|
670
|
|
|
‡a
Author's Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
|
|
670
|
|
|
‡a
Author's Diagnostic strategies towards clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer
|
|
670
|
|
|
‡a
Author's Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients
|
|
670
|
|
|
‡a
Author's Direct detection of early-stage cancers using circulating tumor DNA.
|
|
670
|
|
|
‡a
Author's Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy.
|
|
670
|
|
|
‡a
Author's DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer
|
|
670
|
|
|
‡a
Author's DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer
|
|
670
|
|
|
‡a
Author's DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
|
|
670
|
|
|
‡a
Author's DNA Copy Number Gains at Loci of Growth Factors and Their Receptors in Salivary Gland Adenoid Cystic Carcinoma
|
|
670
|
|
|
‡a
Author's DNA copy number profiles of gastric cancer precursor lesions
|
|
670
|
|
|
‡a
Author's DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
|
|
670
|
|
|
‡a
Author's DNA quality assessment for array CGH by isothermal whole genome amplification.
|
|
670
|
|
|
‡a
Author's Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study
|
|
670
|
|
|
‡a
Author's Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study
|
|
670
|
|
|
‡a
Author's Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment
|
|
670
|
|
|
‡a
Author's EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study
|
|
670
|
|
|
‡a
Author's Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice
|
|
670
|
|
|
‡a
Author's Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer
|
|
670
|
|
|
‡a
Author's Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas
|
|
670
|
|
|
‡a
Author's Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.
|
|
670
|
|
|
‡a
Author's Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations
|
|
670
|
|
|
‡a
Author's Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence
|
|
670
|
|
|
‡a
Author's Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
|
|
670
|
|
|
‡a
Author's Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy
|
|
670
|
|
|
‡a
Author's Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study
|
|
670
|
|
|
‡a
Author's Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis
|
|
670
|
|
|
‡a
Author's Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack
|
|
670
|
|
|
‡a
Author's FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
|
|
670
|
|
|
‡a
Author's Functional microRNA screening using a comprehensive lentiviral human microRNA expression library
|
|
670
|
|
|
‡a
Author's Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands
|
|
670
|
|
|
‡a
Author's Gastric cancers of Western European and African patients show different patterns of genomic instability
|
|
670
|
|
|
‡a
Author's GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
|
|
670
|
|
|
‡a
Author's Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
|
|
670
|
|
|
‡a
Author's Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
|
|
670
|
|
|
‡a
Author's GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.
|
|
670
|
|
|
‡a
Author's Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases
|
|
670
|
|
|
‡a
Author's Genome-wide cell-free DNA fragmentation in patients with cancer
|
|
670
|
|
|
‡a
Author's Genomic aberrations relate early and advanced stage ovarian cancer
|
|
670
|
|
|
‡a
Author's Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.
|
|
670
|
|
|
‡a
Author's Genomic landscape of metastatic colorectal cancer
|
|
670
|
|
|
‡a
Author's Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.
|
|
670
|
|
|
‡a
Author's Genomic profiling of gastric cancer predicts lymph node status and survival
|
|
670
|
|
|
‡a
Author's Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
|
|
670
|
|
|
‡a
Author's Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
|
|
670
|
|
|
‡a
Author's Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis
|
|
670
|
|
|
‡a
Author's Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results
|
|
670
|
|
|
‡a
Author's High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
|
|
670
|
|
|
‡a
Author's High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
|
|
670
|
|
|
‡a
Author's High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
|
|
670
|
|
|
‡a
Author's High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
|
|
670
|
|
|
‡a
Author's High-Resolution Array Comparative Genomic Hybridization in Sporadic and Celiac Disease-Related Small Bowel Adenocarcinomas
|
|
670
|
|
|
‡a
Author's High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q.
|
|
670
|
|
|
‡a
Author's Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
|
|
670
|
|
|
‡a
Author's Human and mouse oligonucleotide-based array CGH.
|
|
670
|
|
|
‡a
Author's IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas
|
|
670
|
|
|
‡a
Author's Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify
|
|
670
|
|
|
‡a
Author's Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
|
|
670
|
|
|
‡a
Author's Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
|
|
670
|
|
|
‡a
Author's Implementation of accurate and fast DNA cytometry by confocal microscopy in 3D.
|
|
670
|
|
|
‡a
Author's Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes
|
|
670
|
|
|
‡a
Author's Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene
|
|
670
|
|
|
‡a
Author's Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
|
|
670
|
|
|
‡a
Author's Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer
|
|
670
|
|
|
‡a
Author's Integration of EGA secure data access into Galaxy
|
|
670
|
|
|
‡a
Author's Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target
|
|
670
|
|
|
‡a
Author's Interval cancers after colonoscopy-insights and recommendations
|
|
670
|
|
|
‡a
Author's KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
|
|
670
|
|
|
‡a
Author's KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
|
|
670
|
|
|
‡a
Author's Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer
|
|
670
|
|
|
‡a
Author's LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
|
|
670
|
|
|
‡a
Author's Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
|
|
670
|
|
|
‡a
Author's Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer
|
|
670
|
|
|
‡a
Author's Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab
|
|
670
|
|
|
‡a
Author's Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
|
|
670
|
|
|
‡a
Author's Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer
|
|
670
|
|
|
‡a
Author's Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated
|
|
670
|
|
|
‡a
Author's Lumican and versican are associated with good outcome in stage II and III colon cancer.
|
|
670
|
|
|
‡a
Author's Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
|
|
670
|
|
|
‡a
Author's MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
|
|
670
|
|
|
‡a
Author's Macrophages direct tumour histology and clinical outcome in a colon cancer model
|
|
670
|
|
|
‡a
Author's Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.
|
|
670
|
|
|
‡a
Author's Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
|
|
670
|
|
|
‡a
Author's MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.
|
|
670
|
|
|
‡a
Author's Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies
|
|
670
|
|
|
‡a
Author's Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components
|
|
670
|
|
|
‡a
Author's MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data.
|
|
670
|
|
|
‡a
Author's Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
|
|
670
|
|
|
‡a
Author's Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA)
|
|
670
|
|
|
‡a
Author's Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
|
|
670
|
|
|
‡a
Author's Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).
|
|
670
|
|
|
‡a
Author's Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
|
|
670
|
|
|
‡a
Author's Molecular tests for colorectal cancer screening
|
|
670
|
|
|
‡a
Author's N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer
|
|
670
|
|
|
‡a
Author's Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative
|
|
670
|
|
|
‡a
Author's Negative NKX2-1
|
|
670
|
|
|
‡a
Author's Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non–Small-Cell Lung Cancer
|
|
670
|
|
|
‡a
Author's NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines
|
|
670
|
|
|
‡a
Author's Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes
|
|
670
|
|
|
‡a
Author's Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
|
|
670
|
|
|
‡a
Author's Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression
|
|
670
|
|
|
‡a
Author's OpenClinica.
|
|
670
|
|
|
‡a
Author's Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
|
|
670
|
|
|
‡a
Author's Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways.
|
|
670
|
|
|
‡a
Author's Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study
|
|
670
|
|
|
‡a
Author's Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
|
|
670
|
|
|
‡a
Author's Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
|
|
670
|
|
|
‡a
Author's Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
|
|
670
|
|
|
‡a
Author's Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer
|
|
670
|
|
|
‡a
Author's Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
|
|
670
|
|
|
‡a
Author's Promoter CpG island methylation markers in colorectal cancer: the road ahead
|
|
670
|
|
|
‡a
Author's Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
|
|
670
|
|
|
‡a
Author's Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer
|
|
670
|
|
|
‡a
Author's Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
|
|
670
|
|
|
‡a
Author's Promoter methylation precedes chromosomal alterations in colorectal cancer development.
|
|
670
|
|
|
‡a
Author's Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
|
|
670
|
|
|
‡a
Author's Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1 Alpha (HIF-1 Alpha )
|
|
670
|
|
|
‡a
Author's Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression
|
|
670
|
|
|
‡a
Author's Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
|
|
670
|
|
|
‡a
Author's Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
|
|
670
|
|
|
‡a
Author's Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
|
|
670
|
|
|
‡a
Author's Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
|
|
670
|
|
|
‡a
Author's Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer
|
|
670
|
|
|
‡a
Author's Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication
|
|
670
|
|
|
‡a
Author's Racial Differences in 3-D Nuclear Chromatin Patterns of Prostate Cancer
|
|
670
|
|
|
‡a
Author's Rapid quantification of myocardial fibrosis: a new macro-based automated analysis
|
|
670
|
|
|
‡a
Author's Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels
|
|
670
|
|
|
‡a
Author's Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
|
|
670
|
|
|
‡a
Author's Reduced rate of copy number aberrations in mucinous colorectal carcinoma
|
|
670
|
|
|
‡a
Author's Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer
|
|
670
|
|
|
‡a
Author's Resolving the resolution of array CGH.
|
|
670
|
|
|
‡a
Author's Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.
|
|
670
|
|
|
‡a
Author's Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study
|
|
670
|
|
|
‡a
Author's Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.
|
|
670
|
|
|
‡a
Author's Salivary gland carcinosarcoma: Oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components
|
|
670
|
|
|
‡a
Author's SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas
|
|
670
|
|
|
‡a
Author's Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis
|
|
670
|
|
|
‡a
Author's Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
|
|
670
|
|
|
‡a
Author's Semi-supervised adaptive-height snipping of the hierarchical clustering tree
|
|
670
|
|
|
‡a
Author's Serrated neoplasia-role in colorectal carcinogenesis and clinical implications
|
|
670
|
|
|
‡a
Author's Similar fecal immunochemical test results in screening and referral colorectal cancer
|
|
670
|
|
|
‡a
Author's Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma
|
|
670
|
|
|
‡a
Author's Smoothing waves in array CGH tumor profiles
|
|
670
|
|
|
‡a
Author's Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
|
|
670
|
|
|
‡a
Author's Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood
|
|
670
|
|
|
‡a
Author's Stepwise classification of cancer samples using clinical and molecular data
|
|
670
|
|
|
‡a
Author's Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
|
|
670
|
|
|
‡a
Author's Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
|
|
670
|
|
|
‡a
Author's Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.
|
|
670
|
|
|
‡a
Author's Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas
|
|
670
|
|
|
‡a
Author's The adenoma hunt in colorectal cancer screening: defining the target
|
|
670
|
|
|
‡a
Author's The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
|
|
670
|
|
|
‡a
Author's The future of colorectal cancer: implications of screening
|
|
670
|
|
|
‡a
Author's The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome
|
|
670
|
|
|
‡a
Author's The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
|
|
670
|
|
|
‡a
Author's The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.
|
|
670
|
|
|
‡a
Author's To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!
|
|
670
|
|
|
‡a
Author's TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
|
|
670
|
|
|
‡a
Author's Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis
|
|
670
|
|
|
‡a
Author's tranSMART.
|
|
670
|
|
|
‡a
Author's Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
|
|
670
|
|
|
‡a
Author's White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
|
|
670
|
|
|
‡a
Author's Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years
|
|
670
|
|
|
‡a
Author's WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
|
|
909
|
|
|
‡a
(orcid) 0000000300570938
‡9
1
|
|
919
|
|
|
‡a
quantitativeanalysisofcdx2proteinexpressionimprovesitsclinicalutilityasaprognosticbiomarkerinstage2and3coloncancer
‡A
Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer
‡9
1
|
|
919
|
|
|
‡a
diagnosisofcolorectaltumoursindailyclinicalpracticecomparisonofcolonoscopyandsigmoidoscopy
‡A
[Diagnosis of colorectal tumours in daily clinical practice: comparison of colonoscopy and sigmoidoscopy]
‡9
1
|
|
919
|
|
|
‡a
developmentandvalidationofthewaspclassificationsystemforopticaldiagnosisofadenomashyperplasticpolypsandsessileserratedadenomaspolyps
‡A
Development and validation of the WASP classification system for optical diagnosis of adenomas, hyperplastic polyps and sessile serrated adenomas/polyps
‡9
1
|
|
919
|
|
|
‡a
quantitativeassessmentofgastricantrumatrophyshowsrestitutiontonormalhistologyafterhelicobacterpylorieradication
‡A
Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication
‡9
1
|
|
919
|
|
|
‡a
determinationofampliconboundariesat20q132intissuesamplesofhumangastricadenocarcinomasbyhighresolutionmicroarraycomparativegenomichybridization
‡A
Determination of amplicon boundaries at 20q13.2 in tissue samples of human gastric adenocarcinomas by high-resolution microarray comparative genomic hybridization
‡9
1
|
|
919
|
|
|
‡a
racialdifferencesin3500nuclearchromatinpatternsofprostatecancer
‡A
Racial Differences in 3-D Nuclear Chromatin Patterns of Prostate Cancer
‡9
1
|
|
919
|
|
|
‡a
detectionlimitsofdnacopynumberalterationsinheterogeneouscellpopulations
‡A
Detection limits of DNA copy number alterations in heterogeneous cell populations
‡9
1
|
|
919
|
|
|
‡a
dendriticcellsrecognizetumorspecificglycosylationofcarcinoembryonicantigenoncolorectalcancercellsthroughdendriticcellspecificintercellularadhesionmolecule3grabbingnonintegrin
‡A
Dendritic cells recognize tumor-specific glycosylation of carcinoembryonic antigen on colorectal cancer cells through dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin.
‡9
1
|
|
919
|
|
|
‡a
rapidquantificationofmyocardialfibrosisanewmacrobasedautomatedanalysis
‡A
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis
‡9
1
|
|
919
|
|
|
‡a
decoyreceptor1dcr1promoterhypermethylationandresponsetoirinotecaninmetastaticcolorectalcancer
‡A
Decoy receptor 1 (DCR1) promoter hypermethylation and response to irinotecan in metastatic colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
cse1ldido1andrbm39incolorectaladenomatocarcinomaprogression
‡A
CSE1L, DIDO1 and RBM39 in colorectal adenoma to carcinoma progression.
‡9
1
|
|
919
|
|
|
‡a
costeffectivenessofhighperformancebiomarkertestsvsfecalimmunochemicaltestfornoninvasivecolorectalcancerscreening
‡A
Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening
‡9
1
|
|
919
|
|
|
‡a
copynumbergainat8q121q221isassociatedwithamalignanttumorphenotypeinsalivaryglandmyoepitheliomas
‡A
Copy number gain at 8q12.1-q22.1 is associated with a malignant tumor phenotype in salivary gland myoepitheliomas.
‡9
1
|
|
919
|
|
|
‡a
implementationofaccurateandfastdnacytometrybyconfocalmicroscopyin3d
‡A
Implementation of accurate and fast DNA cytometry by confocal microscopy in 3D.
‡9
1
|
|
919
|
|
|
‡a
identificationofkeygenesforcarcinogenicpathwaysassociatedwithcolorectaladenomatocarcinomaprogression
‡A
Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
‡9
1
|
|
919
|
|
|
‡a
identificationofgenesputativelyinvolvedinthepathogenesisofdiffuselargebcelllymphomasbyintegrativegenomics
‡A
Identification of genes putatively involved in the pathogenesis of diffuse large B-cell lymphomas by integrative genomics.
‡9
1
|
|
919
|
|
|
‡a
realtimemonitoringofresultsduring1yearofdutchcolorectalcancerscreeningprogramandoptimizationbyalteringfecalimmunochemicaltestcutofflevels
‡A
Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels
‡9
1
|
|
919
|
|
|
‡a
reducedgenomictumorheterogeneityafterneoadjuvantchemotherapyisrelatedtofavorableoutcomeinpatientswithesophagealadenocarcinoma
‡A
Reduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma
‡9
1
|
|
919
|
|
|
‡a
reducedrateofcopynumberaberrationsinmucinouscolorectalcarcinoma
‡A
Reduced rate of copy number aberrations in mucinous colorectal carcinoma
‡9
1
|
|
919
|
|
|
‡a
regulationoftheadenomatouspolyposiscoligenebythemir135familyincolorectalcancer
‡A
Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
endoscopictrimodalimagingversusstandardvideoendoscopyfordetectionofearlybarrettsneoplasiaamulticenterrandomizedcrossoverstudyingeneralpractice
‡A
Endoscopic trimodal imaging versus standard video endoscopy for detection of early Barrett's neoplasia: a multicenter, randomized, crossover study in general practice
‡9
1
|
|
919
|
|
|
‡a
egfrmutationanalysisinsputumoflungcancerpatientsamultitechniquestudy
‡A
EGFR mutation analysis in sputum of lung cancer patients: a multitechnique study
‡9
1
|
|
919
|
|
|
‡a
identificationofdifferentiallyexpressedsplicevariantsbytheproteogenomicpipelinesplicify
‡A
Identification of differentially expressed splice variants by the proteogenomic pipeline Splicify
‡9
1
|
|
919
|
|
|
‡a
ibdassociateddysplasticlesionsshowmorechromosomalinstabilitythansporadicadenomas
‡A
IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas
‡9
1
|
|
919
|
|
|
‡a
humanandmouseoligonucleotidebasedarraycgh
‡A
Human and mouse oligonucleotide-based array CGH.
‡9
1
|
|
919
|
|
|
‡a
higherfecalimmunochemicaltestcutofflevelslowerpositivityratesbutstillacceptabledetectionratesforearlystagecolorectalcancers
‡A
Higher fecal immunochemical test cutoff levels: lower positivity rates but still acceptable detection rates for early-stage colorectal cancers.
‡9
1
|
|
919
|
|
|
‡a
coordinatedepidermalgrowthfactorreceptorpathwaygeneoverexpressionpredictsepidermalgrowthfactorreceptorinhibitorsensitivityinpancreaticcancer
‡A
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
‡9
1
|
|
919
|
|
|
‡a
highresolutionmicroarraycghandmlpaanalysisforimprovedgenotypephenotypeevaluationof2childhoodgeneticdisordercasesringchromosome19andpartialduplication2q
‡A
High resolution microarray CGH and MLPA analysis for improved genotype/phenotype evaluation of two childhood genetic disorder cases: ring chromosome 19 and partial duplication 2q.
‡9
1
|
|
919
|
|
|
‡a
doublesomaticmutationsinmismatchrepairgenesarefrequentincolorectalcancerafterhodgkinslymphomatreatment
‡A
Double somatic mutations in mismatch repair genes are frequent in colorectal cancer after Hodgkin's lymphoma treatment
‡9
1
|
|
919
|
|
|
‡a
consensusmolecularsubtypeclassificationofcolorectaladenomas
‡A
Consensus molecular subtype classification of colorectal adenomas
‡9
1
|
|
919
|
|
|
‡a
doublesamplingofafaecalimmunochemicaltestisnotsuperiortosinglesamplingfordetectionofcolorectalneoplasiaacolonoscopycontrolledprospectivecohortstudy
‡A
Double sampling of a faecal immunochemical test is not superior to single sampling for detection of colorectal neoplasia: a colonoscopy controlled prospective cohort study
‡9
1
|
|
919
|
|
|
‡a
highresolutionarraycomparativegenomichybridizationinsporadicandceliacdiseaserelatedsmallboweladenocarcinomas
‡A
High-Resolution Array Comparative Genomic Hybridization in Sporadic and Celiac Disease-Related Small Bowel Adenocarcinomas
‡9
1
|
|
919
|
|
|
‡a
computerassistedestimationinthecnsof3dmultimarkeroverlaportouchatthelevelofindividualnerveendingsaconfocallaserscanningmicroscopeapplication
‡A
Computer-assisted estimation in the CNS of 3D multimarker 'overlap' or 'touch' at the level of individual nerve endings: a confocal laser scanning microscope application.
‡9
1
|
|
919
|
|
|
‡a
comprehensivemutationanalysisincolorectalflatadenomas
‡A
Comprehensive mutation analysis in colorectal flat adenomas
‡9
1
|
|
919
|
|
|
‡a
highresolutionanalysisofdnacopynumberaberrationsofchromosomes813and20ingastriccancers
‡A
High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers
‡9
1
|
|
919
|
|
|
‡a
highprevalenceofadvancedcolorectalneoplasiaandserratedpolyposissyndromeinhodgkinlymphomasurvivors
‡A
High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors
‡9
1
|
|
919
|
|
|
‡a
comparativegenomichybridizationincancerinvestigations
‡A
Comparative genomic hybridization in cancer investigations
‡9
1
|
|
919
|
|
|
‡a
highprevalenceandclinicalrelevanceofgenesaffectedbychromosomalbreaksincolorectalcancer
‡A
High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
‡9
1
|
|
919
|
|
|
‡a
comparativeevaluationofgeneticassaystoidentifyoralprecancerousfields
‡A
Comparative evaluation of genetic assays to identify oral pre-cancerous fields
‡9
1
|
|
919
|
|
|
‡a
commentreacomparisonofdnacopynumberprofilingplatforms
‡A
Comment re: a comparison of DNA copy number profiling platforms
‡9
1
|
|
919
|
|
|
‡a
combinationofa6micrornaexpressionprofilewith4clinicopathologicalfactorsforresponsepredictionofsystemictreatmentinpatientswithadvancedcolorectalcancer
‡A
Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
highlevelcopynumbergainsofestablishedandpotentialdrugtargetgenesingastriccancerasaleadfortreatmentdevelopmentandselection
‡A
High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.
‡9
1
|
|
919
|
|
|
‡a
hemorrhoidsdetectedatcolonoscopyaninfrequentcauseoffalsepositivefecalimmunochemicaltestresults
‡A
Hemorrhoids detected at colonoscopy: an infrequent cause of false-positive fecal immunochemical test results
‡9
1
|
|
919
|
|
|
‡a
colorectalcarcinomainthenetherlandsthesituationbeforeandafterpopulationsurveillance
‡A
[Colorectal carcinoma in the Netherlands: the situation before and after population surveillance]
‡9
1
|
|
919
|
|
|
‡a
colorectalcancersurveillanceinhodgkinlymphomasurvivorsatincreasedriskoftherapyrelatedcolorectalcancerstudydesign
‡A
Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design
‡9
1
|
|
919
|
|
|
‡a
colorectalcancerepigeneticscomplexsimplicity
‡A
Colorectal cancer epigenetics: complex simplicity
‡9
1
|
|
919
|
|
|
‡a
colorectalcancercandidatebiomarkersidentifiedbytissuesecretomeproteomeprofiling
‡A
Colorectal cancer candidate biomarkers identified by tissue secretome proteome profiling
‡9
1
|
|
919
|
|
|
‡a
colorectaladenomatocarcinomaprogressionisaccompaniedbychangesingeneexpressionassociatedwithageingchromosomalinstabilityandfattyacidmetabolism
‡A
Colorectal adenoma to carcinoma progression is accompanied by changes in gene expression associated with ageing, chromosomal instability, and fatty acid metabolism.
‡9
1
|
|
919
|
|
|
‡a
proteomicsincolorectalcancertranslationalresearchbiomarkerdiscoveryforclinicalapplications
‡A
Proteomics in colorectal cancer translational research: biomarker discovery for clinical applications.
‡9
1
|
|
919
|
|
|
‡a
glucosetransporter1slc2a1andvascularendothelialgrowthfactoravegfapredictsurvivalafterresectionofcolorectalcancerlivermetastasis
‡A
Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis
‡9
1
|
|
919
|
|
|
‡a
genomicstabilityandfunctionalactivitymaybelostintelomerasetransducedhumancd8+tlymphocytes
‡A
Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes
‡9
1
|
|
919
|
|
|
‡a
proteinsinstoolasbiomarkersfornoninvasivedetectionofcolorectaladenomaswithhighriskofprogression
‡A
Proteins in stool as biomarkers for non-invasive detection of colorectal adenomas with high risk of progression
‡9
1
|
|
919
|
|
|
‡a
genomicprofilingofstage2and3coloncancersrevealsapcmutationstobeassociatedwithsurvivalinstage3coloncancerpatients
‡A
Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
‡9
1
|
|
919
|
|
|
‡a
genomicprofilingofgastriccancerpredictslymphnodestatusandsurvival
‡A
Genomic profiling of gastric cancer predicts lymph node status and survival
‡9
1
|
|
919
|
|
|
‡a
proteinexpressionofbcelllymphomagene6bcl6ininvasivebreastcancerisassociatedwithcyclind1andhypoxiainduciblefactor1 Alpha hif1 Alpha
‡A
Protein expression of B-cell lymphoma gene 6 (BCL-6) in invasive breast cancer is associated with cyclin D1 and hypoxia-inducible factor-1 Alpha (HIF-1 Alpha )
‡9
1
|
|
919
|
|
|
‡a
genomicprofilingidentifiescommonhpvassociatedchromosomalalterationsinsquamouscellcarcinomasofcervixandheadandneck
‡A
Genomic profiling identifies common HPV-associated chromosomal alterations in squamous cell carcinomas of cervix and head and neck.
‡9
1
|
|
919
|
|
|
‡a
prospectivecrosssectionalstudyonfaecalimmunochemicaltestssexspecificcutoffvaluestoobtainequalsensitivityforcolorectalcancer
‡A
Prospective cross-sectional study on faecal immunochemical tests: sex specific cut-off values to obtain equal sensitivity for colorectal cancer?
‡9
1
|
|
919
|
|
|
‡a
promotermethylationprecedeschromosomalalterationsincolorectalcancerdevelopment
‡A
Promoter methylation precedes chromosomal alterations in colorectal cancer development.
‡9
1
|
|
919
|
|
|
‡a
promotermethylationofwntantagonistsinpolypoidandnonpolypoidcolorectaladenomas
‡A
Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
‡9
1
|
|
919
|
|
|
‡a
genomiclandscapeofmetastaticcolorectalcancer
‡A
Genomic landscape of metastatic colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
genomicalterationsinprimarygastricadenocarcinomascorrelatewithclinicopathologicalcharacteristicsandsurvival
‡A
Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.
‡9
1
|
|
919
|
|
|
‡a
genomicaberrationsrelateearlyandadvancedstageovariancancer
‡A
Genomic aberrations relate early and advanced stage ovarian cancer
‡9
1
|
|
919
|
|
|
‡a
genomewidecellfreednafragmentationinpatientswithcancer
‡A
Genome-wide cell-free DNA fragmentation in patients with cancer
‡9
1
|
|
919
|
|
|
‡a
geneticheterogeneityinpatientswithmultipleneoplasticlunglesionsareportof3cases
‡A
Genetic heterogeneity in patients with multiple neoplastic lung lesions: a report of three cases
‡9
1
|
|
919
|
|
|
‡a
genebreakdetectionofrecurrentdnacopynumberaberrationassociatedchromosomalbreakpointswithingenes
‡A
GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes.
‡9
1
|
|
919
|
|
|
‡a
geneexpressionprofilesofesophagealsquamouscellcancersinhodgkinlymphomasurvivorsversussporadiccases
‡A
Gene expression profiles of esophageal squamous cell cancers in Hodgkin lymphoma survivors versus sporadic cases
‡9
1
|
|
919
|
|
|
‡a
genedosagedependentoverexpressionatthe13qampliconidentifiesdis3ascandidateoncogeneincolorectalcancerprogression
‡A
Gene-dosage dependent overexpression at the 13q amplicon identifies DIS3 as candidate oncogene in colorectal cancer progression.
‡9
1
|
|
919
|
|
|
‡a
gata4andgata5arepotentialtumorsuppressorsandbiomarkersincolorectalcancer
‡A
GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
doesdelayindiagnosingcolorectalcancerinsymptomaticpatientsaffecttumorstageandsurvivalapopulationbasedobservationalstudy
‡A
Does delay in diagnosing colorectal cancer in symptomatic patients affect tumor stage and survival? A population-based observational study
‡9
1
|
|
919
|
|
|
‡a
colorectaladenomatocarcinomaprogressionfollowsmultiplepathwaysofchromosomalinstability
‡A
Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability
‡9
1
|
|
919
|
|
|
‡a
colonoscopicyieldofcolorectalneoplasiaindailyclinicalpractice
‡A
Colonoscopic yield of colorectal neoplasia in daily clinical practice
‡9
1
|
|
919
|
|
|
‡a
increasedriskofesophagealsquamouscellcarcinomainpatientswithgastricatrophyindependentoftheseverityofatrophicchanges
‡A
Increased risk of esophageal squamous cell carcinoma in patients with gastric atrophy: independent of the severity of atrophic changes
‡9
1
|
|
919
|
|
|
‡a
proximalfluidproteomeprofilingofmousecolontumorsrevealsbiomarkersforearlydiagnosisofhumancolorectalcancer
‡A
Proximal fluid proteome profiling of mouse colon tumors reveals biomarkers for early diagnosis of human colorectal cancer.
‡9
1
|
|
919
|
|
|
‡a
clinicaleffectsofadjuvantactivespecificimmunotherapydifferbetweenpatientswithmicrosatellitestableandmicrosatelliteinstablecoloncancer
‡A
Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer
‡9
1
|
|
919
|
|
|
‡a
chromosome5qlossincolorectalflatadenomas
‡A
Chromosome 5q loss in colorectal flat adenomas.
‡9
1
|
|
919
|
|
|
‡a
promoterdnamethylationofoncostatin1000receptorbetaasanoveldiagnosticandtherapeuticmarkerincoloncancer
‡A
Promoter DNA methylation of oncostatin m receptor-beta as a novel diagnostic and therapeutic marker in colon cancer
‡9
1
|
|
919
|
|
|
‡a
chromosome20p11gainsareassociatedwithliverspecificmetastasisinpatientswithcolorectalcancer
‡A
Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
promotercpgislandmethylationofretpredictspoorprognosisinstage2colorectalcancerpatients
‡A
Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients
‡9
1
|
|
919
|
|
|
‡a
chromosome20aberrationsatthediploidaneuploidtransitioninsporadiccolorectalcancer
‡A
Chromosome 20 aberrations at the diploid-aneuploid transition in sporadic colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
chromosomalsignaturesofasubsetofhighgradepremalignantcervicallesionscloselyresembleinvasivecarcinomas
‡A
Chromosomal signatures of a subset of high-grade premalignant cervical lesions closely resemble invasive carcinomas.
‡9
1
|
|
919
|
|
|
‡a
chromosomalcopynumberaberrationsincolorectalmetastasesresembletheirprimarycounterpartsanddifferencesaretypicallynonrecurrent
‡A
Chromosomal copy number aberrations in colorectal metastases resemble their primary counterparts and differences are typically non-recurrent
‡9
1
|
|
919
|
|
|
‡a
promotercpgislandmethylationmarkersincolorectalcancertheroadahead
‡A
Promoter CpG island methylation markers in colorectal cancer: the road ahead
‡9
1
|
|
919
|
|
|
‡a
diagnosticstrategiestowardsclinicalimplementationofliquidbiopsyrasbrafcirculatingtumordnaanalysesinpatientswithmetastaticcolorectalcancer
‡A
Diagnostic strategies towards clinical implementation of liquid biopsy RAS/BRAF circulating tumor DNA analyses in patients with metastatic colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
chromosomalchangesinrelationtoclinicaloutcomeinlarynxandpharynxsquamouscellcarcinoma
‡A
Chromosomal changes in relation to clinical outcome in larynx and pharynx squamous cell carcinoma.
‡9
1
|
|
919
|
|
|
‡a
expressionandpossibleroleofhpttg1securinincutaneousmalignantmelanoma
‡A
Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma.
‡9
1
|
|
919
|
|
|
‡a
dnaqualityassessmentforarraycghbyisothermalwholegenomeamplification
‡A
DNA quality assessment for array CGH by isothermal whole genome amplification.
‡9
1
|
|
919
|
|
|
‡a
cghpowerexploringsamplesizecalculationsforchromosomalcopynumberexperiments
‡A
CGHpower: exploring sample size calculations for chromosomal copy number experiments
‡9
1
|
|
919
|
|
|
‡a
cgharrayscomparedfordnaisolatedfromformalinfixedparaffinembeddedmaterial
‡A
CGH arrays compared for DNA isolated from formalin-fixed, paraffin-embedded material
‡9
1
|
|
919
|
|
|
‡a
expressionmicroarrayanalysisandoligoarraycomparativegenomichybridizationofacquiredgemcitabineresistanceinmousecolonrevealsselectionforchromosomalaberrations
‡A
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations
‡9
1
|
|
919
|
|
|
‡a
dnamethylationofphosphataseandactinregulator3detectscolorectalcancerinstoolandcomplementsfit
‡A
DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
‡9
1
|
|
919
|
|
|
‡a
cervixsmearabnormalitieslinkingpathologydatainfemaletwinstheirmothersandsisters
‡A
Cervix smear abnormalities: linking pathology data in female twins, their mothers and sisters
‡9
1
|
|
919
|
|
|
‡a
promotercpgislandhypermethylationandh3k9me3andh3k27me3mediatedepigeneticsilencingtargetsthedeletedincoloncancer700geneincolorectalcarcinogenesiswithoutaffectingneighboringgenesonchromosomalregion18q21
‡A
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21.
‡9
1
|
|
919
|
|
|
‡a
promotercpgislandhypermethylationandh3k9me3andh3k27me3mediatedepigeneticsilencingtargetsthedeletedincoloncancer
‡A
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer
‡9
1
|
|
919
|
|
|
‡a
centromericchromosomaltranslocationsshowtissuespecificdifferencesbetweensquamouscellcarcinomasandadenocarcinomas
‡A
Centromeric chromosomal translocations show tissue-specific differences between squamous cell carcinomas and adenocarcinomas.
‡9
1
|
|
919
|
|
|
‡a
expressionofapoptosisregulatingproteinsidentifiesstage2and3coloncancerpatientswithhighriskofrecurrence
‡A
Expression of apoptosis regulating proteins identifies stage II and III colon cancer patients with high risk of recurrence
‡9
1
|
|
919
|
|
|
‡a
differentialglycosylationofmuc1andceacam5betweennormalmucosaandtumourtissueofcoloncancerpatients
‡A
Differential glycosylation of MUC1 and CEACAM5 between normal mucosa and tumour tissue of colon cancer patients
‡9
1
|
|
919
|
|
|
‡a
prognosticvalueofmicrovesseldensityinstage2and3coloncancerpatientsaretrospectivecohortstudy
‡A
Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study
‡9
1
|
|
919
|
|
|
‡a
cellsurfaceproteomicsidentifiesglucosetransportertype1andprionproteinascandidatebiomarkersforcolorectaladenomatocarcinomaprogression
‡A
Cell surface proteomics identifies glucose transporter type 1 and prion protein as candidate biomarkers for colorectal adenoma-to-carcinoma progression.
‡9
1
|
|
919
|
|
|
‡a
cellfreednainthesupernatantofpleuraleffusioncanbeusedtodetectdriverandresistancemutationsandcanguidetyrosinekinaseinhibitortreatmentdecisions
‡A
Cell-free DNA in the supernatant of pleural effusion can be used to detect driver and resistance mutations, and can guide tyrosine kinase inhibitor treatment decisions
‡9
1
|
|
919
|
|
|
‡a
cellcycleproteinspredictrecurrenceinstage2and3coloncancer
‡A
Cell cycle proteins predict recurrence in stage II and III colon cancer.
‡9
1
|
|
919
|
|
|
‡a
presenceofhif1andrelatedgenesinnormalmucosaadenomasandcarcinomasofthecolorectum
‡A
Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
‡9
1
|
|
919
|
|
|
‡a
cd31positivemicrovesseldensitywithinadenomasoflynchsyndromepatientsissimilarcomparedtoadenomasofnonlynchpatients
‡A
CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
‡9
1
|
|
919
|
|
|
‡a
expressionoftheimmunemodulatorsecretoryleukocyteproteaseinhibitorslpiincolorectalcancerlivermetastasesandmatchedprimarytumorsisassociatedwithapoorerprognosis
‡A
Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
‡9
1
|
|
919
|
|
|
‡a
carcinomaorigindictatesdifferentialskewingofmonocytefunction
‡A
Carcinoma origin dictates differential skewing of monocyte function
‡9
1
|
|
919
|
|
|
‡a
candidatedrivergenesinfocalchromosomalaberrationsofstage2coloncancer
‡A
Candidate driver genes in focal chromosomal aberrations of stage II colon cancer
‡9
1
|
|
919
|
|
|
‡a
canabiomarkertriagetestreducecolonoscopyburdeninfecalimmunochemicaltestscreening
‡A
Can a biomarker triage test reduce colonoscopy burden in fecal immunochemical test screening?
‡9
1
|
|
919
|
|
|
‡a
preoperativegranulocytemacrophagecolonystimulatingfactorgmcsfincreaseshepaticdendriticcellnumbersandclusteringwithlymphocytesincolorectalcancerpatients
‡A
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
‡9
1
|
|
919
|
|
|
‡a
diagnosticaccuracyofstooltestsforcolorectalcancersurveillanceinhodgkinlymphomasurvivors
‡A
Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors
‡9
1
|
|
919
|
|
|
‡a
bridgingthetranslationalinnovationgapthroughgoodbiomarkerpractice
‡A
Bridging the translational innovation gap through good biomarker practice.
‡9
1
|
|
919
|
|
|
‡a
breakpointidentificationandsmoothingofarraycomparativegenomichybridizationdata
‡A
Breakpoint identification and smoothing of array comparative genomic hybridization data
‡9
1
|
|
919
|
|
|
‡a
extentandlocationoftumorinfiltratinglymphocytesinmicrosatellitestablecoloncancerpredictoutcometoadjuvantactivespecificimmunotherapy
‡A
Extent and Location of Tumor-Infiltrating Lymphocytes in Microsatellite-Stable Colon Cancer Predict Outcome to Adjuvant Active Specific Immunotherapy
‡9
1
|
|
919
|
|
|
‡a
biopsystrategiesforendoscopicsurveillanceofpremalignantgastriclesions
‡A
Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions
‡9
1
|
|
919
|
|
|
‡a
premalignantgastriclesionsinpatientswithgastricmucosaassociatedlymphoidtissuelymphomaandmetachronousgastricadenocarcinomaacasecontrolstudy
‡A
Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: a case-control study
‡9
1
|
|
919
|
|
|
‡a
beyondkrasmutationstatusinfluenceofkrascopynumberstatusandmicrornasonclinicaloutcometocetuximabinmetastaticcolorectalcancerpatients
‡A
Beyond KRAS mutation status: influence of KRAS copy number status and microRNAs on clinical outcome to cetuximab in metastatic colorectal cancer patients.
‡9
1
|
|
919
|
|
|
‡a
wrnpromotercpgislandhypermethylationdoesnotpredictmorefavorableoutcomesforpatientswithmetastaticcolorectalcancertreatedwithirinotecanbasedtherapy
‡A
WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy
‡9
1
|
|
919
|
|
|
‡a
faecalimmunochemicaltestaccuracyinpatientsreferredforsurveillancecolonoscopyamulticentrecohortstudy
‡A
Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study
‡9
1
|
|
919
|
|
|
‡a
whyiscoloncancersurvivalimprovingbytimeanationwidesurvivalanalysisspanning35years
‡A
Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years
‡9
1
|
|
919
|
|
|
‡a
dnacopynumberprofilesofgastriccancerprecursorlesions
‡A
DNA copy number profiles of gastric cancer precursor lesions
‡9
1
|
|
919
|
|
|
‡a
bcl2l1hasafunctionalroleincolorectalcanceranditsproteinexpressionisassociatedwithchromosome20qgain
‡A
BCL2L1 has a functional role in colorectal cancer and its protein expression is associated with chromosome 20q gain
‡9
1
|
|
919
|
|
|
‡a
focalaberrationsindicateeya2andhsamir375asoncogeneandtumorsuppressorincervicalcarcinogenesis
‡A
Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis
‡9
1
|
|
919
|
|
|
‡a
pla2g2aattenuatescolontumorigenesisinazoxymethanetreatedc57bl6miceexpressionstudiesrevealpla2g2atargetgenesandpathways
‡A
Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways.
‡9
1
|
|
919
|
|
|
‡a
barrettsoesophaguspatientswithlowgradedysplasiacanbeaccuratelyriskstratifiedafterhistologicalreviewbyanexpertpathologypanel
‡A
Barrett's oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel
‡9
1
|
|
919
|
|
|
‡a
barrettsadenocarcinomasresembleadenocarcinomasofthegastriccardiaintermsofchromosomalcopynumberchangesbutrelatetosquamouscellcarcinomasofthedistaloesophaguswithrespecttothepresenceofhighlevelamplifications
‡A
Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications.
‡9
1
|
|
919
|
|
|
‡a
bactothefutureoroligonucleotidesaperspectiveformicroarraycomparativegenomichybridizationarraycgh
‡A
BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH)
‡9
1
|
|
919
|
|
|
‡a
aurorakinaseaaurkainteractionwithwntandrasmapksignallingpathwaysincolorectalcancer
‡A
Aurora kinase A (AURKA) interaction with Wnt and Ras-MAPK signalling pathways in colorectal cancer.
‡9
1
|
|
919
|
|
|
‡a
assessingopportunitiesforcoordinatedr&dinearlycancerdetectionandmanagementineurope
‡A
Assessing opportunities for coordinated R&D in early cancer detection and management in Europe
‡9
1
|
|
919
|
|
|
‡a
whitebloodcellandcellfreednaanalysesfordetectionofresidualdiseaseingastriccancer
‡A
White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer
‡9
1
|
|
919
|
|
|
‡a
arraycomparativegenomichybridizationcopynumberprofilinganewtoolfortranslationalresearchinsolidmalignancies
‡A
Array comparative genomic hybridization copy number profiling: a new tool for translational research in solid malignancies
‡9
1
|
|
919
|
|
|
‡a
anticipatingimplementationofcolorectalcancerscreeninginthenetherlandsanationwidesurveyonendoscopicsupplyanddemand
‡A
Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand
‡9
1
|
|
919
|
|
|
‡a
antibeta1integrinantibodyreducessurgeryinducedadhesionofcoloncarcinomacellstotraumatizedperitonealsurfaces
‡A
Anti-beta1 integrin antibody reduces surgery-induced adhesion of colon carcinoma cells to traumatized peritoneal surfaces
‡9
1
|
|
919
|
|
|
‡a
analyticalsensitivityandstabilityofdnamethylationtestinginstoolsamplesforcolorectalcancerdetection
‡A
Analytical sensitivity and stability of DNA methylation testing in stool samples for colorectal cancer detection.
‡9
1
|
|
919
|
|
|
‡a
focalchromosomalcopynumberaberrationsincancerneedlesinagenomehaystack
‡A
Focal chromosomal copy number aberrations in cancer-Needles in a genome haystack
‡9
1
|
|
919
|
|
|
‡a
americanassociationforcancerresearchprojectgenomicsevidenceneoplasiainformationexchangefrominceptionto1datareleaseandbeyondlessonslearnedandmemberinstitutionsperspectives
‡A
American Association for Cancer Research Project Genomics Evidence Neoplasia Information Exchange: From Inception to First Data Release and Beyond—Lessons Learned and Member Institutions’ Perspectives
‡9
1
|
|
919
|
|
|
‡a
treatmentstrategiesincolorectalcancerpatientswithinitiallyunresectableliveronlymetastasesastudyprotocoloftherandomisedphase3cairo5studyofthedutchcolorectalcancergroupdccg
‡A
Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
‡9
1
|
|
919
|
|
|
‡a
dnacopynumbergainsatlociofgrowthfactorsandtheirreceptorsinsalivaryglandadenoidcysticcarcinoma
‡A
DNA Copy Number Gains at Loci of Growth Factors and Their Receptors in Salivary Gland Adenoid Cystic Carcinoma
‡9
1
|
|
919
|
|
|
‡a
alternativecleavageandpolyadenylationduringcolorectalcancerdevelopment
‡A
Alternative Cleavage and Polyadenylation during Colorectal Cancer Development
‡9
1
|
|
919
|
|
|
‡a
adhesionmoleculesinperitonealdisseminationfunctionprognosticrelevanceandtherapeuticoptions
‡A
Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options
‡9
1
|
|
919
|
|
|
‡a
performanceofampliconbasednextgenerationdnasequencingfordiagnosticgenemutationprofilinginoncopathology
‡A
Performance of amplicon-based next generation DNA sequencing for diagnostic gene mutation profiling in oncopathology.
‡9
1
|
|
919
|
|
|
‡a
openclinica
‡A
OpenClinica.
‡9
1
|
|
919
|
|
|
‡a
gastriccancersofwesterneuropeanandafricanpatientsshowdifferentpatternsofgenomicinstability
‡A
Gastric cancers of Western European and African patients show different patterns of genomic instability
‡9
1
|
|
919
|
|
|
‡a
dnacopynumberanalysisoffreshandformalinfixedspecimensbyshallowwholegenomesequencingwithidentificationandexclusionofproblematicregionsinthegenomeassembly
‡A
DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly
‡9
1
|
|
919
|
|
|
‡a
krasandbrafmutationanalysisinroutinemoleculardiagnosticscomparisonof3testingmethodsonformalinfixedparaffinembeddedtumorderiveddna
‡A
KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.
‡9
1
|
|
919
|
|
|
‡a
oncogenicroleofmir15a3pin13qamplicondrivencolorectaladenomatocarcinomaprogression
‡A
Oncogenic Role of miR-15a-3p in 13q Amplicon-Driven Colorectal Adenoma-to-Carcinoma Progression
‡9
1
|
|
919
|
|
|
‡a
gastriccancerriskinpatientswithpremalignantgastriclesionsanationwidecohortstudyinthenetherlands
‡A
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands
‡9
1
|
|
919
|
|
|
‡a
novelstoolbasedproteinbiomarkersforimprovedcolorectalcancerscreeningacasecontrolstudy
‡A
Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
‡9
1
|
|
919
|
|
|
‡a
nontemplatednucleotideadditionsdistinguishthesmallrnacompositionincellsfromexosomes
‡A
Nontemplated nucleotide additions distinguish the small RNA composition in cells from exosomes
‡9
1
|
|
919
|
|
|
‡a
nmdinhibitionfailstoidentifytumoursuppressorgenesinmicrosatellitestablegastriccancercelllines
‡A
NMD inhibition fails to identify tumour suppressor genes in microsatellite stable gastric cancer cell lines
‡9
1
|
|
919
|
|
|
‡a
negativenkx21ttf1astemporarysurrogatemarkerfortreatmentselectionduringegfrmutationanalysisinpatientswithnonsmallcelllungcancer
‡A
Negative NKX2-1 (TTF-1) as Temporary Surrogate Marker for Treatment Selection During EGFR-Mutation Analysis in Patients with Non–Small-Cell Lung Cancer
‡9
1
|
|
919
|
|
|
‡a
negativenkx21
‡A
Negative NKX2-1
‡9
1
|
|
919
|
|
|
‡a
lackofmicrorna101causesecadherinfunctionalderegulationthroughezh2upregulationinintestinalgastriccancer
‡A
Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer
‡9
1
|
|
919
|
|
|
‡a
nationwidecomprehensivegastrointestinalcancercohortsthe3pinitiative
‡A
Nationwide comprehensive gastro-intestinal cancer cohorts: the 3P initiative
‡9
1
|
|
919
|
|
|
‡a
nmycdownstreamregulatedgene4ndrg4acandidatetumorsuppressorgeneandpotentialbiomarkerforcolorectalcancer
‡A
N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
lohofptprjoccursearlyincolorectalcancerandisassociatedwithchromosomallossof18q1221
‡A
LOH of PTPRJ occurs early in colorectal cancer and is associated with chromosomal loss of 18q12-21.
‡9
1
|
|
919
|
|
|
‡a
moleculartestsforcolorectalcancerscreening
‡A
Molecular tests for colorectal cancer screening
‡9
1
|
|
919
|
|
|
‡a
proteomicsofdifferentialextractionfractionsenrichedforchromatinbindingproteinsfromcolonadenomaandcarcinomatissues
‡A
Proteomics of differential extraction fractions enriched for chromatin-binding proteins from colon adenoma and carcinoma tissues.
‡9
1
|
|
919
|
|
|
‡a
transmart
‡A
tranSMART.
‡9
1
|
|
919
|
|
|
‡a
trackingthemolecularfeaturesofnonpolypoidcolorectalneoplasmsasystematicreviewandmetaanalysis
‡A
Tracking the molecular features of nonpolypoid colorectal neoplasms: a systematic review and meta-analysis
‡9
1
|
|
919
|
|
|
‡a
dnacopynumberalterationsinendobronchialsquamousmetaplasticlesionspredictlungcancer
‡A
DNA copy number alterations in endobronchial squamous metaplastic lesions predict lung cancer
‡9
1
|
|
919
|
|
|
‡a
functionalmicrornascreeningusingacomprehensivelentiviralhumanmicrornaexpressionlibrary
‡A
Functional microRNA screening using a comprehensive lentiviral human microRNA expression library
‡9
1
|
|
919
|
|
|
‡a
evaluationofcancerassociateddnacopynumbereventsincolorectaladvancedadenomas
‡A
Evaluation of Cancer-Associated DNA Copy Number Events in Colorectal (Advanced) Adenomas
‡9
1
|
|
919
|
|
|
‡a
inhibitionofgastriccancerinvasionandmetastasisbypla2g2aanovelbetacatenintcftargetgene
‡A
Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene
‡9
1
|
|
919
|
|
|
‡a
acrossarraycomparativegenomichybridizationastrategytoreducereferencechannelhybridizations
‡A
Across array comparative genomic hybridization: a strategy to reduce reference channel hybridizations
‡9
1
|
|
919
|
|
|
‡a
tpx2andaurkapromote20qamplicondrivencolorectaladenomatocarcinomaprogression
‡A
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
‡9
1
|
|
919
|
|
|
‡a
acquiredgenomicaberrationsassociatedwithmethotrexateresistancevarywithbackgroundgenomicinstability
‡A
Acquired genomic aberrations associated with methotrexate resistance vary with background genomic instability
‡9
1
|
|
919
|
|
|
‡a
focalcallanrpackagefortheannotationoffocalcopynumberaberrations
‡A
FocalCall: An R Package for the Annotation of Focal Copy Number Aberrations
‡9
1
|
|
919
|
|
|
‡a
molecularstooltestingasanalternativeforsurveillancecolonoscopyacrosssectionalcohortstudy
‡A
Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
‡9
1
|
|
919
|
|
|
‡a
abstract4526lumicanandversicanpredictgoodoutcomeinstage2and3coloncancer
‡A
Abstract 4526: Lumican and Versican predict good outcome in stage II and III colon cancer
‡9
1
|
|
919
|
|
|
‡a
abstract3426anovelapproachtocopynumberassessmentbywholegenomesequencingrevealsextensivespatialheterogeneityindiffuselowgradeglioma
‡A
Abstract 3426: A novel approach to copy number assessment by whole genome sequencing reveals extensive spatial heterogeneity in diffuse low-grade glioma
‡9
1
|
|
919
|
|
|
‡a
abstract3397patternsofdnacopynumberchangesincolorectalcancermetastasisarehighlysimilartotheircorrespondingprimarieswithadditionalfocalalterationsthatdifferbetweenindividualpatients
‡A
Abstract 3397: Patterns of DNA copy number changes in colorectal cancer metastasis are highly similar to their corresponding primaries with additional focal alterations that differ between individual patients
‡9
1
|
|
919
|
|
|
‡a
abstract3042tpx2andaurkapromote20qamplicondrivencolorectaladenomatocarcinomaprogression
‡A
Abstract 3042: TPX2 and AURKA promote 20q amplicon driven colorectal adenoma-to-carcinoma progression
‡9
1
|
|
919
|
|
|
‡a
abstract109cse1la20qgainpassengerthatdrivescolorectaladenomatocarcinomaprogression
‡A
Abstract 109: CSE1L, a 20q gain passenger that drives colorectal adenoma to carcinoma progression
‡9
1
|
|
919
|
|
|
‡a
prognosticclassifierforpatientswithcolorectalcancerlivermetastasisbasedonaurkaptgs2andmmp9
‡A
A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.
‡9
1
|
|
919
|
|
|
‡a
integratedanalysisofchromosomalmicrosatelliteandepigeneticinstabilityincolorectalcanceridentifiesspecificassociationsbetweenpromotermethylationofpivotaltumoursuppressoranddnarepairgenesandspecificchromosomalalterations
‡A
Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations.
‡9
1
|
|
919
|
|
|
‡a
todnaornottodnathatisthequestionwhenitcomestomolecularsubtypingfortheclinic
‡A
To DNA or not to DNA? That is the question, when it comes to molecular subtyping for the clinic!
‡9
1
|
|
919
|
|
|
‡a
potentialofimagingtechniquesasascreeningtoolforcolorectalcanceracosteffectivenessanalysis
‡A
The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis.
‡9
1
|
|
919
|
|
|
‡a
lumicanandversicanareassociatedwithgoodoutcomeinstage2and3coloncancer
‡A
Lumican and versican are associated with good outcome in stage II and III colon cancer.
‡9
1
|
|
919
|
|
|
‡a
melanomamaicareframeworkamicrosimulationmodelfortheassessmentofindividualizedcancercare
‡A
The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
‡9
1
|
|
919
|
|
|
‡a
landscapeofgenomiccopynumberalterationsincolorectalcancerandtheirconsequencesongeneexpressionlevelsanddiseaseoutcome
‡A
The landscape of genomic copy number alterations in colorectal cancer and their consequences on gene expression levels and disease outcome
‡9
1
|
|
919
|
|
|
‡a
futureofcolorectalcancerimplicationsofscreening
‡A
The future of colorectal cancer: implications of screening
‡9
1
|
|
919
|
|
|
‡a
molecularimagingofaurorakinaseaaurkaexpressionsynthesisandpreclinicalevaluationofradiolabeledalisertib1050
‡A
Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).
‡9
1
|
|
919
|
|
|
‡a
100typelectinmglexpressedbydendriticcellsdetectsglycanchangesonmuc1incoloncarcinoma
‡A
The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma.
‡9
1
|
|
919
|
|
|
‡a
adenomahuntincolorectalcancerscreeningdefiningthetarget
‡A
The adenoma hunt in colorectal cancer screening: defining the target
‡9
1
|
|
919
|
|
|
‡a
integratedgenomicandtranscriptionalprofilingidentifieschromosomallociwithalteredgeneexpressionincervicalcancer
‡A
Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer
‡9
1
|
|
919
|
|
|
‡a
lumicanandversicanproteinexpressionareassociatedwithcolorectaladenomatocarcinomaprogression
‡A
Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
‡9
1
|
|
919
|
|
|
‡a
macrod2expressionpredictsresponseto5fubasedchemotherapyinstage3coloncancer
‡A
MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
‡9
1
|
|
919
|
|
|
‡a
macrophagesdirecttumourhistologyandclinicaloutcomeinacoloncancermodel
‡A
Macrophages direct tumour histology and clinical outcome in a colon cancer model
‡9
1
|
|
919
|
|
|
‡a
longtermimpactofthedutchcolorectalcancerscreeningprogramoncancerincidenceandmortalitymodelbasedexplorationoftheserratedpathway
‡A
Long-Term Impact of the Dutch Colorectal Cancer Screening Program on Cancer Incidence and Mortality-Model-Based Exploration of the Serrated Pathway.
‡9
1
|
|
919
|
|
|
‡a
methylationmediatedsilencingandtumoursuppressivefunctionofhsamir124incervicalcancer
‡A
Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.
‡9
1
|
|
919
|
|
|
‡a
methylationoftfpi2instooldnaapotentialnovelbiomarkerforthedetectionofcolorectalcancer
‡A
Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
mglligandexpressioniscorrelatedtobrafmutationandassociatedwithpoorsurvivalofstage3coloncancerpatients
‡A
MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.
‡9
1
|
|
919
|
|
|
‡a
integrationofegasecuredataaccessintogalaxy
‡A
Integration of EGA secure data access into Galaxy
‡9
1
|
|
919
|
|
|
‡a
lowgradedysplasiainbarrettsesophagusoverdiagnosedandunderestimated
‡A
Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated
‡9
1
|
|
919
|
|
|
‡a
mismatchrepairstatusandbrafmutationstatusinmetastaticcolorectalcancerpatientsapooledanalysisofthecairocairo2coinandfocusstudies
‡A
Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies
‡9
1
|
|
919
|
|
|
‡a
mixedgastriccarcinomasshowsimilarchromosomalaberrationsinboththeirdiffuseandglandularcomponents
‡A
Mixed gastric carcinomas show similar chromosomal aberrations in both their diffuse and glandular components
‡9
1
|
|
919
|
|
|
‡a
lossesofchromosome5qand14qareassociatedwithfavorableclinicaloutcomeofpatientswithgastriccancer
‡A
Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer
‡9
1
|
|
919
|
|
|
‡a
integrationofgenedosageandgeneexpressioninnonsmallcelllungcanceridentificationofhsp90aspotentialtarget
‡A
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target
‡9
1
|
|
919
|
|
|
‡a
resolvingtheresolutionofarraycgh
‡A
Resolving the resolution of array CGH.
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationofcolorectaladenomasrevealspofut1asacandidatedriveroftumorprogression
‡A
Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
‡9
1
|
|
919
|
|
|
‡a
intervalcancersaftercolonoscopyinsightsandrecommendations
‡A
Interval cancers after colonoscopy-insights and recommendations
‡9
1
|
|
919
|
|
|
‡a
lossof1p36gainof8q24andlossof9q34areassociatedwithstromapercentageofcolorectalcancer
‡A
Loss of 1p36, gain of 8q24, and loss of 9q34 are associated with stroma percentage of colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
kcnq1andlymphovascularinvasionarekeyfeaturesinaprognosticclassifierforstage2and3coloncancer
‡A
KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
‡9
1
|
|
919
|
|
|
‡a
riskofcolorectalcancerinpatientswithbarrettsesophagusadutchpopulationbasedstudy
‡A
Risk of colorectal cancer in patients with Barrett's esophagus: A Dutch population-based study.
‡9
1
|
|
919
|
|
|
‡a
riskofmalignantprogressioninpatientswithbarrettsoesophagusadutchnationwidecohortstudy
‡A
Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study
‡9
1
|
|
919
|
|
|
‡a
runx1isatumorsuppressorgeneinthemousegastrointestinaltract
‡A
Runx1 is a tumor suppressor gene in the mouse gastrointestinal tract.
‡9
1
|
|
919
|
|
|
‡a
salivaryglandcarcinosarcomaoligonucleotidearraycghrevealssimilargenomicprofilesinepithelialandmesenchymalcomponents
‡A
Salivary gland carcinosarcoma: Oligonucleotide array CGH reveals similar genomic profiles in epithelial and mesenchymal components
‡9
1
|
|
919
|
|
|
‡a
satb2incombinationwithcytokeratin20identifiesover95ofallcolorectalcarcinomas
‡A
SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas
‡9
1
|
|
919
|
|
|
‡a
screeningforcolorectalcancerwithfecalimmunochemicaltestingwithandwithoutpostpolypectomysurveillancecolonoscopyacosteffectivenessanalysis
‡A
Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis
‡9
1
|
|
919
|
|
|
‡a
selectionofproteinkinaseinhibitorsbasedontumortissuekinaseactivityprofilesinpatientswithrefractorysolidmalignanciesaninterventionalmolecularprofilingstudy
‡A
Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
‡9
1
|
|
919
|
|
|
‡a
lossofkcnq1expressioninstage2andstage3coloncancerisastrongprognosticfactorfordiseaserecurrence
‡A
Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
‡9
1
|
|
919
|
|
|
‡a
modelingtheadenomaandserratedpathwaytocolorectalcancerascca
‡A
Modeling the Adenoma and Serrated pathway to Colorectal CAncer (ASCCA)
‡9
1
|
|
919
|
|
|
‡a
directdetectionofearlystagecancersusingcirculatingtumordna
‡A
Direct detection of early-stage cancers using circulating tumor DNA.
‡9
1
|
|
919
|
|
|
‡a
testperformanceofimmunologicfecaloccultbloodtestingandsigmoidoscopycomparedwithprimarycolonoscopyscreeningforcolorectaladvancedadenomas
‡A
Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas
‡9
1
|
|
919
|
|
|
‡a
systematicallylinkingtransmartgalaxyandegaforreusinghumantranslationalresearchdata
‡A
Systematically linking tranSMART, Galaxy and EGA for reusing human translational research data.
‡9
1
|
|
919
|
|
|
‡a
subnuclearproteomicsincolorectalcanceridentificationofproteinsenrichedinthenuclearmatrixfractionandregulationinadenomatocarcinomaprogression
‡A
Subnuclear proteomics in colorectal cancer: identification of proteins enriched in the nuclear matrix fraction and regulation in adenoma to carcinoma progression.
‡9
1
|
|
919
|
|
|
‡a
studyprotocolwholegenomesequencingimplementationinstandarddiagnosticsforeverycancerpatientwide
‡A
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE)
‡9
1
|
|
919
|
|
|
‡a
epigeneticsilencingofcyclooxygenase2affectsclinicaloutcomeingastriccancer
‡A
Epigenetic silencing of cyclooxygenase-2 affects clinical outcome in gastric cancer
‡9
1
|
|
919
|
|
|
‡a
simultaneouschromosome1qgainand16qlossisassociatedwithsteroidreceptorpresenceandlowproliferationinbreastcarcinoma
‡A
Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma
‡9
1
|
|
919
|
|
|
‡a
modelingpersonalizedadjuvanttreatmentinearlystagecoloncancerpattern
‡A
Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
‡9
1
|
|
919
|
|
|
‡a
discriminationbetweenbenignandmalignantprostatetissueusingchromatintextureanalysisin3500byconfocallaserscanningmicroscopy
‡A
Discrimination between benign and malignant prostate tissue using chromatin texture analysis in 3-D by confocal laser scanning microscopy.
‡9
1
|
|
919
|
|
|
‡a
dnacopynumberaberrationsinendobronchiallesionsavalidatedpredictorforcancer
‡A
DNA copy number aberrations in endobronchial lesions: a validated predictor for cancer
‡9
1
|
|
919
|
|
|
‡a
mlpanalyzerdataanalysistoolforreliableautomatednormalizationofmlpafragmentdata
‡A
MLPAnalyzer: data analysis tool for reliable automated normalization of MLPA fragment data.
‡9
1
|
|
919
|
|
|
‡a
stepwiseclassificationofcancersamplesusingclinicalandmoleculardata
‡A
Stepwise classification of cancer samples using clinical and molecular data
‡9
1
|
|
919
|
|
|
‡a
similarfecalimmunochemicaltestresultsinscreeningandreferralcolorectalcancer
‡A
Similar fecal immunochemical test results in screening and referral colorectal cancer
‡9
1
|
|
919
|
|
|
‡a
spectrinrepeatcontainingnuclearenvelope1andforkheadboxproteine1arepromisingmarkersforthedetectionofcolorectalcancerinblood
‡A
Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood
‡9
1
|
|
919
|
|
|
‡a
spatialandtemporalevolutionofdistal10qdeletionaprognosticallyunfavorableeventindiffuselowgradegliomas
‡A
Spatial and temporal evolution of distal 10q deletion, a prognostically unfavorable event in diffuse low-grade gliomas
‡9
1
|
|
919
|
|
|
‡a
semisupervisedadaptiveheightsnippingofthehierarchicalclusteringtree
‡A
Semi-supervised adaptive-height snipping of the hierarchical clustering tree
‡9
1
|
|
919
|
|
|
‡a
serratedneoplasiaroleincolorectalcarcinogenesisandclinicalimplications
‡A
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications
‡9
1
|
|
919
|
|
|
‡a
lossofchromosome18q112q121ispredictiveforsurvivalinpatientswithmetastaticcolorectalcancertreatedwithbevacizumab
‡A
Loss of Chromosome 18q11.2-q12.1 Is Predictive for Survival in Patients With Metastatic Colorectal Cancer Treated With Bevacizumab
‡9
1
|
|
919
|
|
|
‡a
smoothingwavesinarraycghtumorprofiles
‡A
Smoothing waves in array CGH tumor profiles
‡9
1
|
|
919
|
|
|
‡a
proteomicsofcolorectalcanceroverviewofdiscoverystudiesandidentificationofcommonlyidentifiedcancerassociatedproteinsandcandidatecrcserummarkers
‡A
Proteomics of colorectal cancer: overview of discovery studies and identification of commonly identified cancer-associated proteins and candidate CRC serum markers.
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000039733886
|
|
996
|
|
|
‡2
BNF|12536406
|
|
996
|
|
|
‡2
NTA|074241443
|
|
996
|
|
|
‡2
ISNI|000000038957458X
|
|
996
|
|
|
‡2
ISNI|0000000495837072
|
|
996
|
|
|
‡2
NTA|093616058
|
|
996
|
|
|
‡2
NTA|285608711
|
|
996
|
|
|
‡2
NTA|070899495
|
|
996
|
|
|
‡2
LC|n 2017009699
|
|
996
|
|
|
‡2
SUDOC|161578217
|
|
996
|
|
|
‡2
LC|n 92083995
|
|
996
|
|
|
‡2
LC|n 82212797
|
|
996
|
|
|
‡2
ISNI|0000000394774324
|
|
996
|
|
|
‡2
ISNI|0000000479765849
|
|
996
|
|
|
‡2
NTA|402244265
|
|
996
|
|
|
‡2
NTA|070935424
|
|
996
|
|
|
‡2
ISNI|0000000115587631
|
|
996
|
|
|
‡2
ISNI|0000000056508736
|
|
996
|
|
|
‡2
RERO|A003580748
|
|
996
|
|
|
‡2
RERO|A003580749
|
|
996
|
|
|
‡2
NTA|394083512
|
|
996
|
|
|
‡2
RERO|A003580747
|
|
996
|
|
|
‡2
ISNI|0000000397172716
|
|
996
|
|
|
‡2
SUDOC|26644962X
|
|
996
|
|
|
‡2
ISNI|0000000394187971
|
|
996
|
|
|
‡2
ISNI|0000000387586878
|
|
996
|
|
|
‡2
NTA|323945007
|
|
996
|
|
|
‡2
ISNI|0000000390763847
|
|
996
|
|
|
‡2
NTA|126595534
|
|
996
|
|
|
‡2
NTA|069360014
|
|
996
|
|
|
‡2
NTA|180636359
|
|
996
|
|
|
‡2
NTA|07493984X
|
|
996
|
|
|
‡2
NTA|213797828
|
|
996
|
|
|
‡2
BAV|495_142216
|
|
996
|
|
|
‡2
DNB|1055190929
|
|
996
|
|
|
‡2
DNB|128479566
|
|
996
|
|
|
‡2
NTA|163775508
|
|
996
|
|
|
‡2
ISNI|000000039037418X
|
|
996
|
|
|
‡2
NTA|074661442
|
|
996
|
|
|
‡2
NUKAT|n 96301185
|
|
996
|
|
|
‡2
ISNI|0000000397817123
|
|
996
|
|
|
‡2
NTA|329608908
|
|
996
|
|
|
‡2
DNB|122205776X
|
|
996
|
|
|
‡2
NTA|107504278
|
|
996
|
|
|
‡2
ISNI|000000044378735X
|
|
996
|
|
|
‡2
RERO|A012516508
|
|
996
|
|
|
‡2
ISNI|0000000394006288
|
|
996
|
|
|
‡2
DNB|172233909
|
|
996
|
|
|
‡2
NTA|436662345
|
|
996
|
|
|
‡2
ISNI|0000000389201548
|
|
996
|
|
|
‡2
NII|DA09253876
|
|
996
|
|
|
‡2
NTA|074668293
|
|
996
|
|
|
‡2
ISNI|0000000081113496
|
|
996
|
|
|
‡2
BIBSYS|90858631
|
|
996
|
|
|
‡2
ISNI|0000000390538463
|
|
996
|
|
|
‡2
NTA|227550196
|
|
996
|
|
|
‡2
NTA|261978152
|
|
996
|
|
|
‡2
NTA|424581655
|
|
996
|
|
|
‡2
NTA|117819891
|
|
996
|
|
|
‡2
NTA|344698114
|
|
996
|
|
|
‡2
DNB|135191858
|
|
996
|
|
|
‡2
ISNI|0000000393915818
|
|
996
|
|
|
‡2
NTA|164028439
|
|
996
|
|
|
‡2
NTA|177039140
|
|
996
|
|
|
‡2
LC|n 2020013644
|
|
996
|
|
|
‡2
NTA|070798486
|
|
996
|
|
|
‡2
NTA|072431318
|
|
996
|
|
|
‡2
SUDOC|034628002
|
|
996
|
|
|
‡2
ISNI|0000000389885169
|
|
996
|
|
|
‡2
NTA|130749699
|
|
996
|
|
|
‡2
DNB|1056191031
|
|
996
|
|
|
‡2
ISNI|000000039150525X
|
|
996
|
|
|
‡2
ISNI|0000000393288914
|
|
996
|
|
|
‡2
NTA|074386247
|
|
996
|
|
|
‡2
LC|n 94048099
|
|
996
|
|
|
‡2
NUKAT|n 2016261236
|
|
996
|
|
|
‡2
DNB|1124562435
|
|
996
|
|
|
‡2
NTA|123837359
|
|
996
|
|
|
‡2
ISNI|0000000023604393
|
|
996
|
|
|
‡2
DNB|134459644
|
|
996
|
|
|
‡2
LC|n 88196366
|
|
996
|
|
|
‡2
ISNI|0000000396701356
|
|
996
|
|
|
‡2
CAOONL|ncf11618932
|
|
996
|
|
|
‡2
ISNI|0000000394000214
|
|
996
|
|
|
‡2
ISNI|0000000394781209
|
|
996
|
|
|
‡2
ISNI|0000000396475352
|
|
996
|
|
|
‡2
ISNI|0000000394252913
|
|
996
|
|
|
‡2
NTA|38048157X
|
|
996
|
|
|
‡2
SUDOC|266817947
|
|
996
|
|
|
‡2
NTA|318986191
|
|
996
|
|
|
‡2
NTA|079913768
|
|
996
|
|
|
‡2
NTA|146072642
|
|
996
|
|
|
‡2
DNB|1089306016
|
|
996
|
|
|
‡2
J9U|987007398683005171
|
|
996
|
|
|
‡2
ISNI|0000000388198367
|
|
996
|
|
|
‡2
J9U|987007339968105171
|
|
996
|
|
|
‡2
NTA|087096277
|
|
996
|
|
|
‡2
SUDOC|250189151
|
|
996
|
|
|
‡2
DNB|137039921
|
|
996
|
|
|
‡2
NTA|159808642
|
|
996
|
|
|
‡2
DNB|1156963192
|
|
996
|
|
|
‡2
NTA|097469289
|
|
996
|
|
|
‡2
BNF|12473722
|
|
996
|
|
|
‡2
LC|no2018021710
|
|
996
|
|
|
‡2
NTA|149309309
|
|
996
|
|
|
‡2
ISNI|0000000389724736
|
|
996
|
|
|
‡2
NII|DA08695981
|
|
996
|
|
|
‡2
NTA|151018545
|
|
996
|
|
|
‡2
ISNI|0000000388311171
|
|
996
|
|
|
‡2
NTA|071129871
|
|
996
|
|
|
‡2
NTA|260351962
|
|
996
|
|
|
‡2
J9U|987007368654505171
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
